{"schema_version":"secwatch.filing_event.v1","accession":"0001104659-24-025580","form_type":"8-K","ticker":"CGTX","cik":"0001455365","company_name":"COGNITION THERAPEUTICS INC","filed_at":"2024-02-20T23:59:59+00:00","discovered_at":"2026-05-14T18:03:24.234370+00:00","generated_at":"2026-06-05T22:59:47.735320+00:00","sec_items":["5.02","9.01"],"event_type":"other","sentiment":"neutral","materiality_score":0.25,"calibrated_materiality_score":0.25,"confidence":"high","headline":"Cognition Therapeutics grants performance stock units to CEO, CFO, and CMO","bullets":["CEO Lisa Ricciardi awarded 150,000 PSUs vesting on clinical milestone achievement.","CFO John Doyle awarded 60,000 PSUs; CMO Anthony Caggiano awarded 130,000 PSUs.","PSUs vest in two equal installments one year after each milestone is met.","Grants made under the 2021 Equity Incentive Plan; no executive departure or appointment.","Compensatory arrangement with no change in company leadership or strategy."],"urls":{"canonical":"https://secwatch.observer/filing/0001104659-24-025580","json":"https://secwatch.observer/filing/0001104659-24-025580.json","markdown":"https://secwatch.observer/filing/0001104659-24-025580.md","text":"https://secwatch.observer/filing/0001104659-24-025580.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1455365/000110465924025580/0001104659-24-025580-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1455365/000110465924025580/tm246515d1_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-05T22:59:47.735320+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}